Biomarkers – News and Features

Researchers have developed a smart, self-powered magnetoelastic pen that can help to detect the early signs of Parkinson's disease by analyzing a person's handwriting.

Inflammation, long considered a hallmark of aging, may not be a universal human experience, according to a new study from Columbia University Mailman School of Public Health.

Scientists at St. Jude Children’s Research Hospital and University Health Network showed that the stage of B-cell development at which leukemia arises impacts B-ALL therapy response and clinical outcome.

A portable diagnostic device that uses a beetle-inspired chemical reaction has shown improved detection of tuberculosis in individuals with HIV, according to a new study.

Researchers at the Keck School of Medicine developed a tau PET imaging cut-point to identify early Alzheimer’s signs. The cut-point distinguished cognitive impairment in Hispanic and non-Hispanic white participants.

This article explores how cancer biomarkers improve early detection, guide treatments and predict outcomes to transform personalized cancer care.

Aggressive forms of acute myeloid leukemia (AML) remain challenging to treat, especially in patients with FLT3-ITD mutations. Researchers have identified a key epigenetic regulator that promotes leukemia cell growth by promoting MYC activation.

A team discovered that patients with Dementia with Lewy Bodies (DLB) have significantly lower levels of α-synuclein in their blood compared to healthy individuals. This finding could lead to a blood-based biomarker for early diagnosis.

Researchers have found that lung cancer patients who have a combination of high levels of depression and inflammation at diagnosis are later found with continuing depressive symptoms in the next several months.

A new, far less invasive capsule sponge test to detect early cancer signs could safely replace the use of regular endoscopies for over half of all patients with Barrett’s oesophagus, a known precursor to oesophageal cancer.